Exemestane and Abilify drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Exemestane (exemestane) and Abilify (aripiprazole). Common drug interactions include clavicle fracture among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Exemestane and Abilify. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Exemestane?

Exemestane has active ingredients of exemestane. It is often used in breast cancer. eHealthMe is studying from 14,038 Exemestane users. Check the latest studies of Exemestane.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.



On Jul, 20, 2026

26 people who take Exemestane and Abilify together, and have interactions are studied.

Exemestane and Abilify drug interactions.

What are the common drug interactions of Exemestane and Abilify, by gender? *:

female:

  1. Clavicle fracture
  2. Cough
  3. Erythema (redness of the skin)
  4. Memory impairment
  5. Osteoporosis (bones weak and more likely to break)
  6. Suicidal ideation
  7. Surgery
  8. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  9. Anxiety
  10. Weight increased

male:

  1. Blood creatinine increased
  2. Death
  3. Urine output decreased
  4. Weight decreased
  5. Decreased appetite
  6. Dehydration (dryness resulting from the removal of water)
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Dyspnoea (difficult or laboured respiration)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Pulmonary oedema (fluid accumulation in the lungs)

What are the common drug interactions of Exemestane and Abilify, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain
  2. Biliary colic
  3. Cholecystitis acute (rapid infection of gallbladder)
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  6. Pancreatitis (inflammation of pancreas)

30-39:

n/a

40-49:

  1. Alopecia (absence of hair from areas of the body)
  2. Anxiety
  3. Hair colour changes
  4. Hair disorder
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Stress

50-59:

  1. Pain
  2. Alopecia (absence of hair from areas of the body)
  3. Anaemia vitamin b12 deficiency
  4. Anxiety
  5. Compression fracture (fracture due to pressure caused by injury)
  6. Disease progression
  7. Drug hypersensitivity
  8. Ear disorder
  9. Emotional distress
  10. Epistaxis (bleed from the nose)

60+:

  1. Decreased appetite
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Fatigue (feeling of tiredness)
  4. Gingivitis (inflammation of gums)
  5. Osteonecrosis of jaw (death of bone of jaw)
  6. Pain
  7. Pulmonary oedema (fluid accumulation in the lungs)
  8. Renal disorder (kidney disease)
  9. Speech disorder
  10. Stomatitis (inflammation of mucous membrane of mouth)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 23.08%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 23.08%
  3. Breast Cancer Metastatic: 6 people, 23.08%
  4. Breast Cancer Female: 5 people, 19.23%
  5. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 11.54%
  6. Type 2 Diabetes: 2 people, 7.69%
  7. High Blood Pressure: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Exemestane and Abilify?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Exemestane and Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exemestane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exemestane and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on exemestane and aripiprazole (the active ingredients of Exemestane and Abilify, respectively), and Exemestane and Abilify (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: